Cross Country Healthcare, Inc. (CCRN)
CCRN Stock Price Chart
Explore Cross Country Healthcare, Inc. interactive price chart. Choose custom timeframes to analyze CCRN price movements and trends.
CCRN Company Profile
Discover essential business fundamentals and corporate details for Cross Country Healthcare, Inc. (CCRN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Care Facilities
IPO Date
25 Oct 2001
Employees
9.61k
CEO
Kevin Cronin Clark
Description
Cross Country Healthcare, Inc. is a U.S.-based provider specializing in talent management and consultative advisory services for healthcare organizations. The company operates through two main divisions: Nurse and Allied Staffing, and Physician Staffing. The Nurse and Allied Staffing segment offers a broad range of recruitment and personnel solutions under the Cross Country brand. This includes both temporary and direct-hire placements for travel nurses, local nurses, and various allied health professionals. It sources registered nurses, licensed practical nurses, certified nurse assistants, practitioners, and pharmacists for per diem or short-term engagements, as well as clinical and non-clinical specialists for longer contract durations. Additionally, this segment delivers comprehensive workforce solutions, including Managed Service Programs (MSP), Recruitment Process Outsourcing (RPO), and consulting, alongside retained and contingent search services for healthcare professionals. Its diverse clientele spans public and private hospitals (both acute and non-acute care), government facilities, national and local healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care centers, and physician practice groups. The Physician Staffing segment, operating as Cross Country Locums, focuses on supplying independent contractor physicians across numerous specialties, certified registered nurse anesthetists (CRNAs), nurse practitioners, and physician assistants. These professionals are deployed on temporary assignments to various healthcare environments, such as acute and non-acute care facilities, medical group practices, government establishments, and managed care organizations. Cross Country Healthcare, Inc. was established in 1986 and is headquartered in Boca Raton, Florida.
CCRN Financial Timeline
Browse a chronological timeline of Cross Country Healthcare, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Aug 2026
EPS estimate is $0.03, while revenue estimate is $242.67m.
Earnings released on 7 May 2026
EPS came in at -$0.03 surpassing the estimated -$0.05 by +40.00%, while revenue for the quarter reached $241.06m , beating expectations by +1.68%.
Earnings released on 4 Mar 2026
EPS came in at -$0.06 falling short of the estimated $0.03 by -300.00%, while revenue for the quarter reached $236.76m , missing expectations by -6.89%.
Earnings released on 12 Nov 2025
EPS came in at $0.03 falling short of the estimated $0.04 by -25.00%, while revenue for the quarter reached $250.05m , missing expectations by -1.67%.
Earnings released on 6 Aug 2025
EPS came in at -$0.01 falling short of the estimated $0.07 by -114.29%, while revenue for the quarter reached $274.07m , missing expectations by -6.66%.
Earnings released on 7 May 2025
EPS came in at $0.06 surpassing the estimated $0.04 by +50.00%, while revenue for the quarter reached $293.41m , missing expectations by -6.80%.
Earnings released on 5 Mar 2025
EPS came in at $0.04 falling short of the estimated $0.11 by -63.64%, while revenue for the quarter reached $309.94m , beating expectations by +1.64%.
Earnings released on 6 Nov 2024
EPS came in at $0.12 surpassing the estimated $0.10 by +20.00%, while revenue for the quarter reached $315.12m , beating expectations by +2.39%.
Earnings released on 31 Jul 2024
EPS came in at $0.10 falling short of the estimated $0.14 by -28.57%, while revenue for the quarter reached $339.77m , beating expectations by +1.50%.
Earnings released on 1 May 2024
EPS came in at $0.19 surpassing the estimated $0.17 by +11.76%, while revenue for the quarter reached $379.17m , beating expectations by +1.36%.
Earnings released on 21 Feb 2024
EPS came in at $0.29 surpassing the estimated $0.27 by +7.41%, while revenue for the quarter reached $414.04m , beating expectations by +2.38%.
Earnings released on 1 Nov 2023
EPS came in at $0.39 falling short of the estimated $0.41 by -4.88%, while revenue for the quarter reached $442.29m , missing expectations by -0.36%.
Earnings released on 2 Aug 2023
EPS came in at $0.69 surpassing the estimated $0.61 by +13.11%, while revenue for the quarter reached $540.70m , beating expectations by +1.70%.
Earnings released on 3 May 2023
EPS came in at $0.84 surpassing the estimated $0.75 by +12.00%, while revenue for the quarter reached $622.71m , beating expectations by +4.66%.
Earnings released on 22 Feb 2023
EPS came in at $1.09 surpassing the estimated $0.89 by +22.47%, while revenue for the quarter reached $628.22m , beating expectations by +5.66%.
Earnings released on 2 Nov 2022
EPS came in at $1.07 surpassing the estimated $0.95 by +12.63%, while revenue for the quarter reached $636.10m , beating expectations by +3.01%.
Earnings released on 3 Aug 2022
EPS came in at $1.40 surpassing the estimated $1.35 by +3.70%, while revenue for the quarter reached $753.56m , beating expectations by +1.70%.
Earnings released on 4 May 2022
EPS came in at $1.70 surpassing the estimated $1.31 by +29.77%, while revenue for the quarter reached $788.73m , beating expectations by +5.78%.
Earnings released on 23 Feb 2022
EPS came in at $1.40 surpassing the estimated $1.35 by +3.70%, while revenue for the quarter reached $640.68m , beating expectations by +4.13%.
Earnings released on 3 Nov 2021
EPS came in at $0.61 surpassing the estimated $0.34 by +79.41%, while revenue for the quarter reached $374.91m , beating expectations by +4.75%.
Earnings released on 4 Aug 2021
EPS came in at $0.47 surpassing the estimated $0.40 by +17.50%, while revenue for the quarter reached $331.83m , meeting expectations.
CCRN Stock Performance
Access detailed CCRN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
